» Articles » PMID: 15780994

Defective Central Tolerance Induction in NOD Mice: Genomics and Genetics

Overview
Journal Immunity
Publisher Cell Press
Date 2005 Mar 23
PMID 15780994
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

The genetic determinism of type-1 diabetes in NOD mice likely involves complementary defects in central T cell tolerance induction and peripheral immunoregulation. To study the contribution of the NOD genetic background to central tolerance, we followed the behavior of BDC2.5 clonotype thymocytes in fetal thymic organ cultures (FTOC). The NOD genetic background encodes a quantitative deficiency in the ability to delete these self-reactive thymocytes and to divert them to the CD8alphaalpha lineage. In genetic analyses, comparing NOD and B6.H2g7 FTOCs, the NOD defect incorporated the influence of several loci (notably ones on chr1 and 3). Microarray analyses assessing FTOCs from the same two strains argued that the NOD abnormality reflects the combined effects of turning down the gene expression program that provokes apoptosis and turning on a new program promoting cell survival. Intersection of the data from the two approaches points to a small set of attractive candidate genes.

Citing Articles

Reduced thymic IL-4 impairs negative T cell selection in nonobese diabetic mice.

Cattin-Roy A, Laffey K, Le L, Schrum A, Zaghouani H J Clin Invest. 2024; 134(23).

PMID: 39621313 PMC: 11601892. DOI: 10.1172/JCI163417.


Activation-induced cytidine deaminase expression by thymic B cells promotes T-cell tolerance and limits autoimmunity.

Lombard-Vadnais F, Chabot-Roy G, Zahn A, Rodriguez Torres S, Di Noia J, Melichar H iScience. 2023; 26(1):105852.

PMID: 36654860 PMC: 9840937. DOI: 10.1016/j.isci.2022.105852.


Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes.

Liu Q, Aseer K, Yao Q, Zhong X, Ghosh P, OConnell J Front Pharmacol. 2022; 12:809965.

PMID: 35115945 PMC: 8804091. DOI: 10.3389/fphar.2021.809965.


Modeling human T1D-associated autoimmune processes.

Khosravi-Maharlooei M, Madley R, Borsotti C, Ferreira L, Sharp R, Brehm M Mol Metab. 2021; 56:101417.

PMID: 34902607 PMC: 8739876. DOI: 10.1016/j.molmet.2021.101417.


Role of the PD-1/PD-L1 Signaling in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Recent Insights and Future Directions.

Mi Y, Han J, Zhu J, Jin T Mol Neurobiol. 2021; 58(12):6249-6271.

PMID: 34480337 PMC: 8639577. DOI: 10.1007/s12035-021-02495-7.